P. Cottagnoud

505 total citations
22 papers, 388 citations indexed

About

P. Cottagnoud is a scholar working on Epidemiology, Microbiology and Pharmacology. According to data from OpenAlex, P. Cottagnoud has authored 22 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 14 papers in Microbiology and 12 papers in Pharmacology. Recurrent topics in P. Cottagnoud's work include Pneumonia and Respiratory Infections (15 papers), Bacterial Infections and Vaccines (14 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). P. Cottagnoud is often cited by papers focused on Pneumonia and Respiratory Infections (15 papers), Bacterial Infections and Vaccines (14 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). P. Cottagnoud collaborates with scholars based in Switzerland, United States and Dominican Republic. P. Cottagnoud's co-authors include M. Cottagnoud, F. Acosta, A. Stucki, M G Täuber, Alexander Tomasz, K Neftel, Jürg H. Beer, Martin G. Täuber, Marc Pfister and Martin Perrig and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

P. Cottagnoud

22 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Cottagnoud Switzerland 13 215 180 117 89 77 22 388
M. Cottagnoud Switzerland 16 366 1.7× 301 1.7× 229 2.0× 170 1.9× 119 1.5× 24 556
S Shelton United States 15 400 1.9× 266 1.5× 294 2.5× 62 0.7× 124 1.6× 24 639
Hugo Trujillo Colombia 11 182 0.8× 73 0.4× 99 0.8× 113 1.3× 45 0.6× 31 336
H Meguro Japan 8 217 1.0× 46 0.3× 80 0.7× 87 1.0× 35 0.5× 64 356
Anabel Fernández Spain 9 187 0.9× 83 0.5× 35 0.3× 36 0.4× 20 0.3× 24 298
Marc Whitman United States 7 80 0.4× 30 0.2× 73 0.6× 117 1.3× 57 0.7× 8 279
M Rylander Sweden 11 105 0.5× 66 0.4× 48 0.4× 61 0.7× 54 0.7× 19 370
Alba Ribera Spain 12 167 0.8× 43 0.2× 126 1.1× 108 1.2× 90 1.2× 25 496
Kalpana B. Patel United States 9 191 0.9× 24 0.1× 198 1.7× 85 1.0× 117 1.5× 12 334

Countries citing papers authored by P. Cottagnoud

Since Specialization
Citations

This map shows the geographic impact of P. Cottagnoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Cottagnoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Cottagnoud more than expected).

Fields of papers citing papers by P. Cottagnoud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Cottagnoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Cottagnoud. The network helps show where P. Cottagnoud may publish in the future.

Co-authorship network of co-authors of P. Cottagnoud

This figure shows the co-authorship network connecting the top 25 collaborators of P. Cottagnoud. A scholar is included among the top collaborators of P. Cottagnoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Cottagnoud. P. Cottagnoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cottagnoud, P., M. Cottagnoud, F. Acosta, & A. Stucki. (2013). Efficacy of Ceftaroline Fosamil against Penicillin-Sensitive and -Resistant Streptococcus pneumoniae in an Experimental Rabbit Meningitis Model. Antimicrobial Agents and Chemotherapy. 57(10). 4653–4655. 17 indexed citations
2.
Stucki, A., F. Acosta, M. Cottagnoud, & P. Cottagnoud. (2013). Efficacy of Ceftaroline Fosamil against Escherichia coli and Klebsiella pneumoniae Strains in a Rabbit Meningitis Model. Antimicrobial Agents and Chemotherapy. 57(12). 5808–5810. 19 indexed citations
3.
Stucki, A., et al.. (2011). Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis. Journal of Antimicrobial Chemotherapy. 67(3). 661–665. 3 indexed citations
4.
5.
Stanga, Zeno, et al.. (2009). Combination of Daptomycin plus Ceftriaxone Is More Active than Vancomycin plus Ceftriaxone in Experimental Meningitis after Addition of Dexamethasone. Antimicrobial Agents and Chemotherapy. 53(7). 3030–3033. 19 indexed citations
6.
Stucki, A., Peter Arne Gerber, F. Acosta, et al.. (2008). Effects of EDP-420 on penicillin-resistant and quinolone- and penicillin-resistant pneumococci in the rabbit meningitis model. Journal of Antimicrobial Chemotherapy. 61(3). 665–669. 9 indexed citations
7.
8.
Stucki, A., P. Cottagnoud, & Stefan Fischli. (2005). Seltene Ursache einer Rechtsherzinsuffizienz: zwei Fälle. DMW - Deutsche Medizinische Wochenschrift. 130(21). 1314–1317. 1 indexed citations
9.
Cottagnoud, P., et al.. (2004). New therapies for pneumococcal meningitis. Expert Opinion on Investigational Drugs. 13(4). 393–401. 5 indexed citations
10.
Cottagnoud, P., Paul Majcherczyk, F. Acosta, et al.. (2003). The Stereochemistry of the Amino Acid Side Chain Influences the Inflammatory Potential of Muramyl Dipeptide in Experimental Meningitis. Infection and Immunity. 71(6). 3663–3666. 7 indexed citations
11.
Kuhn, Félix P., M. Cottagnoud, F. Acosta, et al.. (2003). Cefotaxime Acts Synergistically with Levofloxacin in Experimental Meningitis Due to Penicillin-Resistant Pneumococci and Prevents Selection of Levofloxacin-Resistant Mutants In Vitro. Antimicrobial Agents and Chemotherapy. 47(8). 2487–2491. 18 indexed citations
12.
Cottagnoud, P.. (2002). Cellular and molecular aspects of drugs of the future: meropenem. Cellular and Molecular Life Sciences. 59(11). 1928–1933. 9 indexed citations
13.
Cottagnoud, P., M. Cottagnoud, & M G Täuber. (2002). Vancomycin Acts Synergistically with Gentamicin against Penicillin-Resistant Pneumococci by Increasing the Intracellular Penetration of Gentamicin. Antimicrobial Agents and Chemotherapy. 47(1). 144–147. 33 indexed citations
14.
Perrig, Martin, et al.. (2001). Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro. Journal of Antimicrobial Chemotherapy. 47(5). 701–704. 15 indexed citations
15.
Cottagnoud, P.. (2000). Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model. Journal of Antimicrobial Chemotherapy. 46(6). 981–985. 55 indexed citations
16.
Furrer, Markus, P. Cottagnoud, & Kathrin Mühlemann. (2000). Haemophilus influenzae Infections among Hospitalized Adult Patients. Infection. 28(6). 351–354. 6 indexed citations
17.
Cottagnoud, M., et al.. (1999). Meropenem Alone and in Combination with Vancomycin in Experimental Meningitis Caused by a Penicillin-Resistant Pneumococcal Strain. European Journal of Clinical Microbiology & Infectious Diseases. 18(12). 866–870. 28 indexed citations
18.
Beer, Jürg H., et al.. (1996). False positive results for leucocytes in urine dipstick test with common antibiotics: Table 1. BMJ. 313(7048). 25–25. 31 indexed citations
19.
Cottagnoud, P. & Alexander Tomasz. (1993). Triggering of Pneumococcal Autolysis by Lysozyme. The Journal of Infectious Diseases. 167(3). 684–690. 31 indexed citations
20.
Neftel, K, Gerald T. Keusch, P. Cottagnoud, et al.. (1988). [Are cephalosporins more active than penicillin G in poisoning with the deadly Amanita?].. PubMed. 118(2). 49–51. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Cottagnoud Breakdown of academic impact, for papers by S Shelton Breakdown of academic impact, for papers by Hugo Trujillo Breakdown of academic impact, for papers by H Meguro Breakdown of academic impact, for papers by Anabel Fernández Breakdown of academic impact, for papers by Marc Whitman Breakdown of academic impact, for papers by M Rylander Breakdown of academic impact, for papers by Alba Ribera Breakdown of academic impact, for papers by Kalpana B. Patel
Rankless by CCL
2026